SOFWF (Sofwave Medical) Tariff Resilience Score: 6/10 (As of Jul. 03, 2026)


SOFWF Sofwave Medical Ltd SOFWF
44 GF Score
Price $14.33
GF Value $9.79
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Sofwave Medical Tariff Resilience Score?

Sofwave Medical SOFWF -10.44% 44 Tariff Resilience Score is 6 as of Jul. 03, 2026. GuruFocus rates SOFWF with a GF Score™ of 44/100 and a GF Value™ of $9.79 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 837 Medical Devices & Instruments companies, Sofwave Medical ranks better than 91.04% on this metric.

Sofwave Medical has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Sofwave Medical has Sofwave Medical has moderate exposure due to its reliance on global suppliers for medical device components. However, its primary market is domestic, reducing direct tariff impact. Historical data shows limited impact from tariffs, and the company has some pricing power to mitigate costs.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Sofwave Medical might have Average Resilient.

Sofwave Medical  (OTCPK:SOFWF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Sofwave Medical Tariff Resilience Score Related Terms

SOFWF vs ABT, SYK, MDT: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Sofwave Medical's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sofwave Medical Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sofwave Medical's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Sofwave Medical's Tariff Resilience Score falls into.


SOFWF
44GF Score
Sofwave Medical Ltd SOFWF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Sofwave Medical (SOFWF) has a Tariff Resilience Score of 6 as of Jul. 03, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Sofwave Medical ranks #75 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 9%.
Is Sofwave Medical's Tariff Resilience Score too high?
Sofwave Medical's current Tariff Resilience Score is 6. Based on the distribution chart, Sofwave Medical ranks #75 out of 837 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sofwave Medical has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sofwave Medical's Tariff Resilience Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sofwave Medical ranks #75 out of 837 companies for Tariff Resilience Score. This places Sofwave Medical in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Sofwave Medical's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sofwave Medical stock overvalued right now?
Based on GuruFocus' analysis, Sofwave Medical (SOFWF) is currently considered Significantly Overvalued. The stock's GF Value™ is $9.79, compared to a current price of $14.33 — trading 46.4% above its estimated fair value. The current Tariff Resilience Score is 6. Sofwave Medical's overall GF Score™ is 44/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Sofwave Medical (SOFWF), the current Tariff Resilience Score is 6 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sofwave Medical (SOFWF) Overvalued in 2026?

Based on GuruFocus' analysis, Sofwave Medical stock appears to be overvalued. The current stock price of $14.33 is trading 46.4% above its estimated GF Value™ of $9.79. GuruFocus considers Sofwave Medical to be Significantly Overvalued.

Key valuation signals for SOFWF:

  • Tariff Resilience Score: 6
  • GF Value™: $9.79 vs. price of $14.33 (46.4% above fair value)
  • GF Score™: 44/100 with 2 warning signs

No single metric tells the full story. See the SOFWF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sofwave Medical Business Description

Other Exchanges SOFW:Israel
Address Oak Medtech, Tavor, Alon Medtech Venture, Yokneam Illit, ISR, 2069200
Sofwave Medical Ltd is engaged in the development, marketing, and production of non-invasive technology for skin rejuvenation and firming treatment.
44GF Score

Get the complete analysis for SOFWF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.33
Price
$9.79
GF Value